Physician profile
Mikhail Kogan
NPI 1467420877
$3,163.30
in general payments reported to CMS, 2019-2025
17 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,852 · 2020: $178 · 2021: $32.08 · 2022: $218 · 2023: $585 · 2024: $47.81 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.98 |
| Travel and Lodging | $410.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,599.19 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $452.53 | 2023 | Iovera |
| Spr Therapeutics, INC | $258.17 | 2022-2025 | Sprint Pns System |
| Horizon Therapeutics Plc | $142.25 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $125.83 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $90.55 | 2024-2025 | |
| Boston Scientific Corporation | $90.43 | 2019-2020 | |
| Bioventus LLC | $69.22 | 2022 | |
| Saluda Medical Americas, INC. | $67.63 | 2023 | Evoke Scs |
| Scilex Pharmaceuticals INC. | $46.62 | 2022 | |
| Depuy Synthes Sales INC. | $43.49 | 2019-2022 | |
| Medtronic USA, INC. | $39.51 | 2019 | |
| Relievant Medsystems, INC. | $37.12 | 2023 | Intracept |
| Forte Bio-Pharma LLC | $27.91 | 2024 | Prolate, Nalocet |
| Almatica Pharma LLC | $27.64 | 2023 | Gralise |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $27.57 | 2020 | |
| Arbor Pharmaceuticals, INC. | $17.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikhail Kogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.